Extensive Enlargement of Hydronephrosis Market: Valuation USD 250 million by 2023, at a CAGR of 10.2%

Hydronephrosis Market
Hydronephrosis Market Information: By Type (Unilateral, Bilateral), By Diagnosis (Laboratory Tests, Imaging), By Treatment (Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Others), And By Indication (Intrinsic, Extrinsic) – Global Forecast Till 2023

Market Research Future published a research report on “Hydronephrosis Market Research Report – Global Forecast Till 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Market Synopsis of the Global Hydronephrosis Market

Market Scenario:

Hydronephrosis is a condition characterized by a swollen kidney as a result of abnormal drainage of urine from the kidney to the bladder. It is a secondary disease that results from primary disease that may affect the kidney. Symptoms of hydronephrosis includes fever, pain when urinating, nausea or vomiting, and pain in the abdomen. It may be unilateral or bilateral. Unilateral hydronephrosis is swelling  of one kidney, whereas, bilateral hydronephrosis is swelling of both the kidneys. Hydronephrosis is mostly diagnosed through ultrasound examination.

Hydronephrosis has become a major problem across the globe due to rising prevalence of kidney diseases, lack of awareness about the diseases and their treatment, which favor the growth of the market. Rising prevalence of kidney diseases especially, in the geriatric population and availability of cost-effective treatment propel the market growth.

The global hydronephrosis market is expected to grow at a CAGR of 10.2% during the forecast period and is estimated to reach USD 250 million by 2023.

Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/4223

Key Players in the Global Hydronephrosis Market

Some of the key players in this market are NephroGenex, Inc. (U.S), American Renal Associates (U.S), PHRAXIS, INC. (U.S), Renal Associates P.A. (U.S), ALLERGAN (U.S), Amgen Inc. (U.S), Anthem Bio Pharm (U.S), Sanofi (U.S), and Novartis AG (Germany)   .

Segments
The global hydronephrosis market is segmented on the basis of types, which includes unilateral hydronephrosis and bilateral hydronephrosis.

On the basis of diagnosis, the market is segmented into laboratory test and imaging. Laboratory test is further segmented into urinalysis, Complete Blood Count (CBC), electrolyte analysis, and others. Imaging is further sub-segmented into CT scan, ultrasound, intravenous pyelography, KUB X-rays, and others.

On the basis of treatment, the market is segmented into shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, and others.

On the basis of indication the market is segmented into intrinsic and extrinsic causes of hydronephrosis. The intrinsic causes are further sub-segmented into acute unilateral obstructive uropathy, kidney stone, bladder cancer, bladder stones, cystocele, urethral stricture, urethral cancer and others. The extrinsic causes are further sub-segmented into retroperitoneal fibrosis, ovarian vein syndrome, cancer of the cervix, cancer of the prostate, uterine prolapse, prostate cancer, and others.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/hydronephrosis-market-4223

Regional Analysis of the Global Hydronephrosis Market

The American region accounted for the largest share of the global market due to increasing prevalence of chronic kidney diseases, and rising demand for diagnosis and treatment of hydronephrosis. Hydronephrosis are leading urological diseases in the U.S. According to the Center for Diseases Control and Prevention, 48,146 deaths occurred due to nephrosis and kidney diseases in the year 2014. It also stated that the number of adults diagnosed with kidney diseases in 2014 was 4.9 million in the US.

Europe is the second largest market that holds a noticeable share of the global hydronephrosis market. According to the European database for surveillance of congenital malformations report, hydronephrosis is prevalence among new born and pregnant women.

In Asia Pacific, rising prevalence of kidney stone, rising geriatric population and growing demand for counselling about hydronephrosis drive the market growth. 

The Middle East & Africa is expected to show a steady growth in this market due constant demand for diagnostics devices, awareness about maternal and child health in most of the African countries and the government efforts to cater primary health need of the population.

The report on the global hydronephrosis market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions

 Continue…

We are thankful for the support and assistance from Hydronephrosis Market Research Report – Global Forecast Till 2023 chain related technical experts and marketing experts during Research Team survey and interviews.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/hydronephrosis-market-4223